Skip to content
TrialScanner

NCT04865159

Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies

Phase 1TerminatedKURALead

Registry record

Lead sponsor
Kura Oncology, Inc.
Conditions
Advanced Solid Tumor
Primary completion
May 2, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04865159 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04865159: Cardiovascular Safety Study... | TrialScanner